MIAMI, Dec. 22, 2015—Global Stem Cells Group announced the appointment of Daniça Goleš to the position of chief international marketing officer for the biotech company. Goleš, who has served in the same capacity for the GSCG headquarters in Chile since 2014, is a specialist in sociology and coaching with a concentration in medicine and surgery, and has 20 years’ experience in medical marketing, management and strategic communications.
Prior to joining Global Stem Cells Group’s team in Chile, Goleš was the director of strategic communication management in the two largest university hospitals in Chile, leading the department for seven years at the University of Chile and another seven years at the Pontifical Catholic University of Chile.
Goleš developed two private strategic consulting practices for the medical and surgical areas of organ transplant teams, digestive surgery, bariatric, rare diseases, orthopedics and plastic surgery for Chile’s most important advocates.
She was a founding partner of Healthvision Ltd., Coach Pacients SA, and Communication and Medicine Ltd. Both companies engaged in the management of medical and health content and validating reliable sources for the media, development and production of television programs and developing business models for clinical management. Goleš establshed policy for improved patient information and improved relationships between the organization’s professionals and end users.
Since beginning her training in 2000 on Chile’s first steps in cell therapy, Goleš developed management models for regenerative medicine patients. Next, she completed internships in Germany and Chicago with stem cell development groups. She is a member of the International Society of Cell Therapy and the International Society for Stem Cell Research (ISSR).
In 2012, she received the Robert Wood Johnson Foundation (Johnson & Johnson) Community Health Leaders award, which honors advocates in the health care industry who have made a difference in improving the health and access to care for patients in underserved populations.
Goleš graduated from the Professional Institute of Santiago and completed her post graduate studies at the Universidad Alberto Hurtado in Santiago, Chile in 2002 with a diploma in Communications and New Technologies. She subsequently completed her masters degree in Psychology and Coaching at the University of Chile Institute of Communications with concentrations in Clinical Units Top Management, strategic planning at Les Halles, Paris and brand management and Internet Domains at the University of Chile.
“We are very happy that Daniça is bringing her skills to our international efforts at a time when the company is growing exponentially worldwide,” says Global Stem Cells Group CEO Benito Novas. “Danica did a remarkable job for us in Chile, and now we can benefit from her talents at the international level.”
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/